CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Treasury Stock	Accumulated Other Comprehensive Income (Loss)	Retained Earnings
Beginning balance (in shares) at Dec. 31, 2023		103,405
Beginning balance at Dec. 31, 2023	$ 506,705	$ 133	$ 738,515	$ (635,078)	$ 609	$ 402,526
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under our incentive award plan (in shares)		786
Issuance of common stock under incentive award plan	3,485		3,485
Shares tendered to satisfy cost and statutory withholding requirements for net settlement of cashless option exercises and vesting of restricted stock (in shares)		(143)
Shares tendered to satisfy cost and statutory withholding requirements for net settlement of cashless option exercises and vesting of restricted stock	(3,554)		2,032	(5,586)
Repurchase of common stock in connection with Stock Repurchase Program (in shares)		(20)
Repurchase of common stock in connection with Stock Repurchase Program	(476)			(476)
Excise tax related to net share repurchases	81			81
Stock-based compensation	12,929		12,929
Vesting of RSAs in connection with ESPP	1,283		1,283
Other comprehensive gain (loss), net of tax	(351)				(351)
Net income	27,762					27,762
Ending balance (in shares) at Mar. 31, 2024		104,028
Ending balance at Mar. 31, 2024	547,864	$ 133	758,244	(641,059)	258	430,288
Beginning balance (in shares) at Dec. 31, 2023		103,405
Beginning balance at Dec. 31, 2023	506,705	$ 133	738,515	(635,078)	609	402,526
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	63,250
Ending balance (in shares) at Jun. 30, 2024		104,398
Ending balance at Jun. 30, 2024	596,243	$ 134	781,012	(650,763)	84	465,776
Beginning balance (in shares) at Mar. 31, 2024		104,028
Beginning balance at Mar. 31, 2024	547,864	$ 133	758,244	(641,059)	258	430,288
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under our incentive award plan (in shares)		700
Issuance of common stock under incentive award plan	7,574	$ 1	7,573
Shares tendered to satisfy cost and statutory withholding requirements for net settlement of cashless option exercises and vesting of restricted stock (in shares)		(208)
Shares tendered to satisfy cost and statutory withholding requirements for net settlement of cashless option exercises and vesting of restricted stock	(6,242)			(6,242)
Repurchase of common stock in connection with Stock Repurchase Program (in shares)		(122)
Repurchase of common stock in connection with Stock Repurchase Program	(3,478)			(3,478)
Excise tax related to net share repurchases	16			16
Stock-based compensation	13,881		13,881
Vesting of RSAs in connection with ESPP	1,314		1,314
Other comprehensive gain (loss), net of tax	(174)
Net income	35,488					35,488
Ending balance (in shares) at Jun. 30, 2024		104,398
Ending balance at Jun. 30, 2024	596,243	$ 134	781,012	(650,763)	84	465,776
Beginning balance (in shares) at Dec. 31, 2024		105,113
Beginning balance at Dec. 31, 2024	679,589	$ 136	832,108	(696,173)	(217)	543,735
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under our incentive award plan (in shares)		1,712
Issuance of common stock under incentive award plan	12,900	$ 1	12,899
Shares tendered to satisfy cost and statutory withholding requirements for net settlement of cashless option exercises and vesting of restricted stock (in shares)		(341)
Shares tendered to satisfy cost and statutory withholding requirements for net settlement of cashless option exercises and vesting of restricted stock	(21,086)		0	(21,086)
Repurchase of common stock in connection with Stock Repurchase Program (in shares)		(500)
Repurchase of common stock in connection with Stock Repurchase Program	(27,433)			(27,433)
Stock-based compensation	15,687		15,687
Vesting of RSAs in connection with ESPP	2,172		2,172
Other comprehensive gain (loss), net of tax	909				909
Net income	20,547					20,547
Ending balance (in shares) at Mar. 31, 2025		105,984
Ending balance at Mar. 31, 2025	683,285	$ 137	862,866	(744,692)	692	564,282
Beginning balance (in shares) at Dec. 31, 2024		105,113
Beginning balance at Dec. 31, 2024	679,589	$ 136	832,108	(696,173)	(217)	543,735
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	55,696
Ending balance (in shares) at Jun. 30, 2025		105,288
Ending balance at Jun. 30, 2025	635,793	$ 138	900,864	(866,931)	2,291	599,431
Beginning balance (in shares) at Mar. 31, 2025		105,984
Beginning balance at Mar. 31, 2025	683,285	$ 137	862,866	(744,692)	692	564,282
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under our incentive award plan (in shares)		1,048
Issuance of common stock under incentive award plan	15,123	$ 1	15,122
Shares tendered to satisfy cost and statutory withholding requirements for net settlement of cashless option exercises and vesting of restricted stock (in shares)		(262)
Shares tendered to satisfy cost and statutory withholding requirements for net settlement of cashless option exercises and vesting of restricted stock	(19,221)			(19,221)
Repurchase of common stock in connection with Stock Repurchase Program (in shares)		(1,482)
Repurchase of common stock in connection with Stock Repurchase Program	(103,018)			(103,018)
Stock-based compensation	19,427		19,427
Vesting of RSAs in connection with ESPP	3,449		3,449
Other comprehensive gain (loss), net of tax	1,599				1,599
Net income	35,149					35,149
Ending balance (in shares) at Jun. 30, 2025		105,288
Ending balance at Jun. 30, 2025	$ 635,793	$ 138	$ 900,864	$ (866,931)	$ 2,291	$ 599,431